Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay.

McAuley JD, Caglioti S, Williams RC, Robertson GF, Morgan L, Tobler LH, Busch MP.

Transfusion. 2004 Jan;44(1):91-6.

PMID:
14692973
2.
3.

Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.

Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos NC, Mimidis K, Karafoulidou A, Hatzakis A.

Vox Sang. 2007 Jan;92(1):8-14.

PMID:
17181585
4.

Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.

Vargo J, Smith K, Knott C, Wang S, Fang C, McDonough S, Giachetti C, Caglioti S, Gammon R, Gilbert D, Jackson JB, Richards W, Stramer S, Mimms L.

Transfusion. 2002 Jul;42(7):876-85.

PMID:
12375660
5.

Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies.

Mison L, Seed CR, Margaritis AR, Hyland C; Australian Red Cross Blood Service Nucleic Acid Technology Study Group.

Vox Sang. 2003 Jan;84(1):11-9.

PMID:
12542729
6.

Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.

Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, Tu Y, Giachetti C, Gallarda J, Heitman J, Kleinman SH; National Heart, Lung, Blood Institute Nucleic Acid Test Study Group*.

Transfusion. 2005 Dec;45(12):1853-63.

PMID:
16371038
7.

Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.

Bamaga MS, Bokhari FF, Aboud AM, Al-Malki M, Alenzi FQ.

Saudi Med J. 2006 Jun;27(6):781-7.

PMID:
16758035
8.

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.

Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.

Transfusion. 2008 Jun;48(6):1198-206. doi: 10.1111/j.1537-2995.2008.01672.x. Epub 2008 Apr 14.

PMID:
18422856
9.

Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.

Jongerius JM, Sjerps M, Cuijpers HT, van Drimmelen HA, van der Poel CL, Reesink HW, Molijn MH, Peeters GA, Peeters TP, Lelie PN.

Transfusion. 2002 Jun;42(6):792-7.

PMID:
12147034
10.

Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.

Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT.

Transfusion. 2005 Aug;45(8):1258-66. Erratum in: Transfusion. 2005 Dec;45(12):1988.

PMID:
16078910
11.

A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.

Shan H, Ren FR, Zhao HY, Zhang YZ, Wen GX, Yao FZ, Gao GJ, Yan LX, Jiang CF, Bai XH, Tiemuer MH, Tu YQ, Zhu FM, Zheng YR, Cui L, Liu CL, Gong XY, Lv QS, Zheng P, Ziermann R, Ness P, Wang JX.

Transfusion. 2007 Nov;47(11):2011-6.

PMID:
17958529
12.

The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.

Ohnuma H, Tanaka T, Yoshikawa A, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY, Miyamoto M, Satoh S, Nakahira S, Tomono T, Murozuka T, Takeda Y, Doi Y, Mine H, Yokoyama S, Hirose T, Nishioka K; Japanese Red Cross NAT Screening Research Group.

Microbiol Immunol. 2001;45(9):667-72.

13.

Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.

Candotti D, Richetin A, Cant B, Temple J, Sims C, Reeves I, Barbara JA, Allain JP.

Transfusion. 2003 Feb;43(2):215-25.

PMID:
12559017
14.

Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.

McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.

J Clin Virol. 2006 Jul;36(3):166-76. Epub 2006 Jan 20.

PMID:
16427802
15.

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.

Roth WK, Weber M, Buhr S, Drosten C, Weichert W, Sireis W, Hedges D, Seifried E.

Transfusion. 2002 Jul;42(7):862-8.

PMID:
12375658
17.

Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.

Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P.

Transfusion. 2009 Feb;49(2):301-10. doi: 10.1111/j.1537-2995.2008.01966.x.

PMID:
19389212
18.

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.

Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C; Working Group for NAT Study in Thai Blood Donations.

Transfusion. 2009 Jun;49(6):1126-35. doi: 10.1111/j.1537-2995.2009.02176.x. Epub 2009 Apr 21.

PMID:
19392770
19.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
20.

Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.

Dettori S, Candido A, Kondili LA, Chionne P, Taffon S, Genovese D, Iudicone P, Miceli M, Rapicetta M.

J Infect. 2009 Aug;59(2):128-33. doi: 10.1016/j.jinf.2009.06.007. Epub 2009 Jun 18.

PMID:
19586663

Supplemental Content

Support Center